Bioqual, Inc.
Rockville, MD
- UEI
- CK9LGQ7EBNN8
- CAGE
- 059B4
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 9600 Medical Center Dr #101, Rockville, MD 20850, USA
- Website
- bioqual.com
- Founded
- 1981
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $4,197,038 |
| FY2025 | $9,354,713 |
| FY2024 | $10,490,496 |
| FY2023 | $18,605,767 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $4,197,038 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Trustees Of The University Of Pennsylvania | R01MH128155 | $197,019 | |
| The Trustees Of The University Of Pennsylvania | R01MH128155 | $623,978 | |
| University Of Maryland, Baltimore | W911NF2320015 | $31,950 | |
| University Of Maryland, Baltimore | W911NF2320015 | $31,324 | |
| Temple University-Of The Commonwealth System Of Higher Education | UM1AI164568 | $88,917 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Bioqual, Inc. is a for-profit biomedical research services company located in Rockville, Maryland, specializing in providing advanced scientific research support to federal agencies. Registered in the System for Award Management (SAM) since 1999, the company offers comprehensive services in animal research, laboratory analysis, and experimental studies across multiple scientific domains. Bioqual primarily serves federal research institutions, with a strong focus on conducting preclinical studies for agencies like the National Institutes of Health (NIH), particularly the National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute, and National Institute of Diabetes and Digestive and Kidney Diseases.
Through federal contract awards, Bioqual has consistently provided sophisticated research services involving animal studies and laboratory analysis. Their contract work spans multiple scientific domains, including infectious disease research, vaccine development, and therapeutic studies. The company has received contracts involving humanized mice studies, SARS-COV-2 hamster research, and non-human primate models for various scientific investigations. Most of their federal contract awards have been firm fixed-price or cost-plus-fixed-fee purchase orders and delivery orders, primarily from NIH institutes. These contracts typically involve conducting specialized research studies, providing laboratory analysis, and supporting animal housing and care. Notably, none of their recent contract awards have been set aside for specific business types, indicating Bioqual competes in open federal procurement processes.
Regarding federal grant awards, Bioqual has been involved in sub-grant work supporting cutting-edge medical research, particularly in HIV cure research and vaccine development. Their grant-related activities have involved collaborating with prominent research institutions like Temple University, University of Maryland, and University of Pennsylvania. These sub-grant projects have focused on innovative research areas such as developing multiomic signatures for vaccine mechanism evaluation, exploring CRISPR technologies for HIV cure strategies, and conducting advanced immunological and virological studies. The grant work demonstrates Bioqual's expertise in supporting complex, interdisciplinary research projects that aim to advance medical understanding and potential therapeutic interventions.
Bioqual holds two significant indefinite delivery contracts (IDVs) that underscore its strategic importance in federal research infrastructure. The first is a $146.3 million single-award IDC with NIAID, running until July 2031, focused on developing and refining animal models for evaluating countermeasures against infectious diseases. This contract covers four primary task areas: small animal models, non-human primate models, animal replacement models, and specialized reagent generation. The second is a $545 million multiple-award IDIQ contract with NIAID's Comprehensive and Rapid Response Research Programs, operating from September 2021 to August 2028. This contract supports a broad range of research services including clinical trials, manufacturing, nonclinical animal studies, analytics, storage, and regulatory support across the agency's research divisions.
Quick answers
Is Bioqual, Inc. registered in SAM.gov?
Yes. Bioqual, Inc.'s SAM.gov registration is active through August 10, 2027.
Which contract vehicles does Bioqual, Inc. hold?
Bioqual, Inc. holds a place on 8 federal contract vehicles, including Comprehensive and Rapid Response to NIAID Research Programs, Pre-Clinical Models of Infectious Diseases and Simian Vaccine Evaluation Units.
How much has Bioqual, Inc. received in federal contracts?
Federal contracts obligated $9,354,713 to Bioqual, Inc. in fiscal year 2025 and $42,648,013 in fiscal years 2023 through 2027.
How does Bioqual, Inc. rank among federal contractors?
Bioqual, Inc. ranked #87 in PSC AN in FY2025.
What is Bioqual, Inc.'s most recent federal award?
Bioqual, Inc.'s most recent federal contract award is Niddk: severable - acquisition of services for humanized mice studies (75N94024P00327), from National Institute of Child Health and Human Development (NIH), on June 5, 2024.
On GovTribe
See Bioqual, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors